🇺🇸 FDA
Patent

US 10124109

Method and device for treating allergic reactions and difficult-to-manage respiratory diseases

granted A61KA61K31/137A61K9/0019

Quick answer

US patent 10124109 (Method and device for treating allergic reactions and difficult-to-manage respiratory diseases) held by Pharmaceutical Design, LLC expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pharmaceutical Design, LLC
Grant date
Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/137, A61K9/0019